Following an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression ...

That is, to advance the use of this drug towards the targeting of 3 undisclosed indications ... Such randomization of ...

and 2.4 mg doses. Interestingly, key results demonstrated a weight loss of 2.2% for the placebo group [3.5 lbs], 10.3% for ...

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

The N-AVD regimen showed improved progression-free survival and lower toxicity than BV-AVD in advanced Hodgkin lymphoma, ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Crisugabalin provides significant improvement in average daily pain score and shows promise as a postherpetic neuralgia treatment.

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

Opponents point to potential health risks from high levels of fluoride, but officials say levels in water are safe and needed ...

Magnesium is an essential mineral with many benefits, such as supporting heart health, reducing inflammation, and maintaining ...

Chinese electric vehicles are proving popular outside the local market and are gaining ground not only in Europe but also in Australia. The MG4 became the country’s best-selling EV in October. With ...

Being started on a smaller dose of the approved early Alzheimer’s therapy Kisunla was found to reduce the risk of ARIA-E on imaging scans.